George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,133.00
Bid: 4,137.00
Ask: 4,139.00
Change: 51.00 (1.25%)
Spread: 2.00 (0.048%)
Open: 4,100.00
High: 4,146.00
Low: 4,097.00
Prev. Close: 4,082.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Director Remuneration Report AGM Vote

30 Oct 2023 16:33

RNS Number : 7569R
Unilever PLC
30 October 2023
 

Unilever PLC

Statement detailing outcome of shareholder engagement following Directors' Remuneration Report (DRR) vote at the Annual General Meeting (AGM) on 3 May 2023

 

At the 2023 AGM, the resolution to receive and adopt the Directors' Remuneration Report (Resolution 2) was not passed, with a minority of 42% of votes cast in favour of the resolution. 

 

Following the AGM, the Company has undertaken an extensive engagement exercise with shareholders to discuss this voting outcome. During this period, we contacted 28 of our largest shareholders representing around 40% of the shares on our shareholder register, inviting them to meet. 24 shareholders accepted this invitation and we conducted a total of 37 meetings during the engagement exercise.

 

The feedback received from this process informed us that the primary reason for the limited support for the DRR was the approach taken to setting the incoming CEO's remuneration on appointment. Specifically, whilst the majority of shareholders agreed that the fixed pay level for the new CEO appropriately reflected the size and complexity of the role, there was a preference that alignment with the market could have been achieved gradually, rather than in one step on appointment.

 

The Compensation Committee considered this feedback carefully and the Board has decided to freeze the CEO's fixed pay for the next two years. Therefore, he will not be eligible for a fixed pay increase in 2024 or 2025, with the Compensation Committee next reviewing his fixed pay level in 2026. This approach of restricting any increases over the first years of appointment is intended to reflect and align with shareholder views in the engagement process that market alignment should be achieved in 2-3 years following appointment.

 

Discussions with shareholders were not limited to the response to the vote. We have also started discussions with shareholders on the renewal of our Remuneration Policy in 2024 and its implementation. The feedback received to date has been valuable and will help to shape our final proposals. We will engage further with shareholders on the Remuneration Policy as required ahead of the Committee finalising the proposed approach which will be published in the remuneration report early next year.

 

We would like to thank all the shareholders who spent time spent engaging with us. The perspectives of our major shareholders are a critical input into the Committee's deliberations, and we continue to be committed to ongoing and open dialogue, including as we consider our 2024 Remuneration Policy.

 

Unilever PLC is publishing this statement as required by the UK Corporate Governance Code in response to the votes received against the DRR resolution at our AGM on 3 May 2023.

 

Andrea Jung

Chair of the Compensation Committee

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRNKKBNABDDBKN
Date   Source Headline
25th Apr 20247:00 amRNSQ1 2024 Trading Statement
2nd Apr 20243:58 pmRNSTotal Voting Rights
28th Mar 20245:04 pmRNSDirector/PDMR Shareholding
27th Mar 202412:32 pmRNSDirector/PDMR Shareholding
26th Mar 20246:13 pmRNSDirector/PDMR Shareholding
26th Mar 202411:58 amRNSDirector/PDMR Shareholding
25th Mar 20243:10 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSUnilever to accelerate Growth Action Plan
18th Mar 20243:00 pmRNSNotice of AGM
14th Mar 20242:14 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSBlock Listing of Shares
11th Mar 20245:55 pmRNSDirector/PDMR Shareholding
1st Mar 20242:36 pmRNSTotal Voting Rights
19th Feb 20243:14 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
1st Feb 20245:04 pmRNSTotal Voting Rights
31st Jan 20243:00 pmRNSDirectorate Change
16th Jan 20245:10 pmRNSBlock listing Interim Review
2nd Jan 20242:54 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20235:48 pmRNSDirector/PDMR Shareholding
12th Dec 20235:51 pmRNSDirector/PDMR Shareholding
11th Dec 20235:48 pmRNSDirector/PDMR Shareholding
11th Dec 20235:43 pmRNSDirector/PDMR Shareholding
4th Dec 20235:28 pmRNSTotal Voting Rights
23rd Nov 20233:51 pmRNSDirector/PDMR Shareholding
22nd Nov 20235:44 pmRNSDirector/PDMR Shareholding
10th Nov 20235:33 pmRNSDirector/PDMR Shareholding
8th Nov 20236:05 pmRNSDirector/PDMR Shareholding
1st Nov 20233:36 pmRNSTotal Voting Rights
30th Oct 20234:33 pmRNSStatement re Director Remuneration Report AGM Vote
26th Oct 20237:01 amRNSUnilever Announces New CFO
26th Oct 20237:00 amRNS3rd Quarter Results
18th Oct 20232:00 pmRNSCompletion of the 4th Tranche Share Buyback
17th Oct 20235:57 pmRNSTransaction in Own Shares
16th Oct 20236:01 pmRNSTransaction in Own Shares
13th Oct 20235:58 pmRNSTransaction in Own Shares
12th Oct 20235:50 pmRNSTransaction in Own Shares
12th Oct 20239:04 amRNSChanges to Membership of Board Committees
11th Oct 20236:06 pmRNSTransaction in Own Shares
11th Oct 20234:37 pmRNSDirector/PDMR Shareholding
10th Oct 20235:42 pmRNSTransaction in Own Shares
9th Oct 20236:05 pmRNSTransaction in Own Shares
6th Oct 20235:55 pmRNSTransaction in Own Shares
5th Oct 20235:46 pmRNSTransaction in Own Shares
4th Oct 20235:54 pmRNSTransaction in Own Shares
3rd Oct 20235:40 pmRNSTransaction in Own Shares
2nd Oct 20236:10 pmRNSTransaction in Own Shares
2nd Oct 20233:57 pmRNSTotal Voting Rights
28th Sep 20236:02 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.